Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Wednesday, March 25, 2015

Cellular Biomedicine Group Announces Interim Results From Phase IIb...

Cellular Biomedicine Group Inc. , a biomedicine firm engaged in the development of effective treatments for degenerative and cancerous diseases, today announced interim 24-week clinical data from the Phase IIb trial of its ReJoinTM human adipose-derived mesenchymal progenitor cell therapy for Knee Osteoarthritis . The data will be discussed by Dr. Wei Cao, PhD, BM, Chief Executive Officer of Cellular Biomedicine Group at the 2015 Annual Regen Med Investor Day at the Metropolitan Club in New York City.

http://ift.tt/1IuMyZP

No comments:

Post a Comment

Popular Stem Cell Roundup Posts